Rhenman & Partners Asset Management’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.7M | Buy |
+985,000
| New | +$3.12M | 0.33% | 74 |
|
|
2025
Q2 | – | Sell |
-1,066,495
| Closed | -$1.54M | – | 96 |
|
|
2025
Q1 | $1.54M | Sell |
1,066,495
-848,505
| -44% | -$1.56M | 0.18% | 73 |
|
|
2024
Q4 | $4.21M | Sell |
1,915,000
-60,000
| -3% | -$140K | 0.43% | 60 |
|
|
2024
Q3 | $3.26M | Hold |
1,975,000
| – | – | 0.26% | 76 |
|
|
2024
Q2 | $4.38M | Buy |
+1,975,000
| New | +$4.65M | 0.42% | 60 |
|
|
2023
Q2 | – | Sell |
-900,000
| Closed | -$1.5M | – | 85 |
|
|
2023
Q1 | $1.5M | Hold |
900,000
| – | – | 0.17% | 80 |
|
|
2022
Q4 | $5.61M | Hold |
900,000
| – | – | 0.59% | 55 |
|
|
2022
Q3 | $7.32M | Hold |
900,000
| – | – | 0.77% | 49 |
|
|
2022
Q2 | $5.72M | Sell |
900,000
-81,582
| -8% | -$463K | 0.65% | 50 |
|
|
2022
Q1 | $4.55M | Sell |
981,582
-18,418
| -2% | -$79K | 0.45% | 64 |
|
|
2021
Q4 | $4.96M | Buy |
1,000,000
+377,733
| +61% | +$3.02M | 0.33% | 73 |
|
|
2021
Q3 | $7.5M | Buy |
622,267
+50,000
| +9% | +$728K | 0.53% | 58 |
|
|
2021
Q2 | $12.1M | Sell |
572,267
-19,958
| -3% | -$481K | 0.82% | 50 |
|
|
2021
Q1 | $16.6M | Hold |
592,225
| – | – | 1.16% | 37 |
|
|
2020
Q4 | $15.4M | Buy |
592,225
+137,225
| +30% | +$4.11M | 1.26% | 35 |
|
|
2020
Q3 | $16.9M | Buy |
455,000
+30,000
| +7% | +$1.19M | 1.5% | 28 |
|
|
2020
Q2 | $21.8M | Sell |
425,000
-167,798
| -28% | -$7.02M | 2.36% | 8 |
|
|
2020
Q1 | $18.7M | Sell |
592,798
-67,202
| -10% | -$3.55M | 2.62% | 8 |
|
|
2019
Q4 | $39.4M | Buy |
660,000
+4,146
| +0.6% | +$186K | 4.31% | 1 |
|
|
2019
Q3 | $24M | Buy |
655,854
+243,761
| +59% | +$9.66M | 3.01% | 5 |
|
|
2019
Q2 | $19.2M | Sell |
412,093
-67,674
| -14% | -$3.18M | 2.11% | 14 |
|
|
2019
Q1 | $19.3M | Buy |
479,767
+125,806
| +36% | +$5.64M | 2.25% | 14 |
|
|
2018
Q4 | $16.3M | Hold |
353,961
| – | – | 1.86% | 20 |
|
|
2018
Q3 | $15.7M | Sell |
353,961
-52,400
| -13% | -$2.41M | 1.57% | 28 |
|
|
2018
Q2 | $15.9M | Buy |
406,361
+161,821
| +66% | +$8.18M | 1.63% | 26 |
|
|
2018
Q1 | $17.7M | Sell |
244,540
-142,086
| -37% | -$10.4M | 2.18% | 14 |
|
|
2017
Q4 | $25.5M | Buy |
386,626
+74,823
| +24% | +$4.03M | 3.44% | 2 |
|
|
2017
Q3 | $15.6M | Sell |
311,803
-51,544
| -14% | -$2.49M | 2% | 16 |
|
|
2017
Q2 | $16.8M | Sell |
363,347
-180,000
| -33% | -$6.62M | 2.41% | 10 |
|
|
2017
Q1 | $19.2M | Buy |
543,347
+268,347
| +98% | +$6.14M | 3.04% | 2 |
|
|
2016
Q4 | $3.44M | Buy |
275,000
+145,000
| +112% | +$1.73M | 0.66% | 57 |
|
|
2016
Q3 | $1.8M | Sell |
130,000
-10,000
| -7% | -$113K | 0.29% | 81 |
|
|
2016
Q2 | $1.38M | Sell |
140,000
-10,000
| -7% | -$166K | 0.25% | 83 |
|
|
2016
Q1 | $2.54M | Buy |
150,000
+50,000
| +50% | +$804K | 0.5% | 68 |
|
|
2015
Q4 | $2.23M | Hold |
100,000
| – | – | 0.34% | 85 |
|
|
2015
Q3 | $2.36M | Sell |
100,000
-12,000
| -11% | -$753K | 0.38% | 70 |
|
|
2015
Q2 | $9.16M | Sell |
112,000
-14,926
| -12% | -$1.46M | 1.3% | 28 |
|
|
2015
Q1 | $11.8M | Sell |
126,926
-23,074
| -15% | -$1.49M | 2.09% | 14 |
|
|
2014
Q4 | $6.07M | Buy |
150,000
+67,079
| +81% | +$2.05M | 1.76% | 16 |
|
|
2014
Q3 | $2.03M | Buy |
+82,921
| New | +$1.32M | 0.62% | 68 |
|
Other funds holding ESPR
WA
TSC
O
VCM
